The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Vascular Complications of Diabetes
Abstract
Over the last several decades, the global incidence and prevalence of diabetes mellitus has increased significantly. The raised incidence rate is projected to continue as greater numbers of persons adopt a Western lifestyle and diet. Patients with diabetes mellitus are at heightened risk of both adverse microvascular and cardiovascular events. Moreover, once cardiovascular disease develops, diabetes mellitus exacerbates progression and worsens outcomes. The medical management of patients with diabetes mellitus mandates comprehensive risk factor modification and antiplatelet therapy. Recent clinical trials of new medical therapies continue to inform the care of patients with diabetes mellitus to reduce both cardiovascular morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“seen in practice, there is an 11-fold increase in retinopathy compared with a 2-fold increase in coronary artery disease.(11)”
Background(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 1×
“In a pooled analysis of 35 studies of diabetic people, collected from 1980 to 2008 from around the world, the prevalence among those 20 to 79 years old was 35% for any retinopathy, 7% for proliferative retinopathy, and 10% for vision threatening retinopathy.(17) Patients of African or Caribbean descent have higher rat…”
BackgroundEzetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 1×
“improved cardiovascular outcomes, with the exception of findings in one trial.(46,140,141) In the FIELD trial, the rate of first”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Green, J. B., Bethel, M. A., Armstrong, P. W., Buse, J. B., Engel, S. S., Garg, J., Josse, R., Kaufman, K. D., Koglin, J., Korn, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501352 · Cited by 2,577
Julius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296
(2000) · PubMed · Cited by 2,095
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67704-5 · Cited by 1,941
Strategies for Multivessel Revascularization in Patients with Diabetes
Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211585 · Cited by 1,922
Adler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196 · cited 1×
“Male sex, higher glycosylated hemoglobin levels, longer duration of diabetes mellitus, higher blood pressure, and use of insulin all were associated with developing retinopathy.(16) In a pooled analysis of 35 studies of diabetic people, collected from 1980 to 2008 from around the world, the prevalence among those 20 t…”
BackgroundBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
Morrow, D. A., Braunwald, E., Bonaca, M. P., Ameriso, S. F., Dalby, A. J., Fish, M. P., Fox, K. A. A., Lipka, L. J., Liu, X., Nicolau, J. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200933 · Cited by 948
Risk factors for myocardial infarction in women and men: insights from the INTERHEART study
Anand, S. S., Islam, S., Rosengren, A., Franzosi, M. G., Steyn, K., Yusufali, A. H., Keltai, M., Diaz, R., Rangarajan, S., & Yusuf, S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn018 · Cited by 909
Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis
Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854
Diehm, C., Schuster, A., Allenberg, J. R., Darius, H., Haberl, R., Lange, S., Pittrow, D., von Stritzky, B., Tepohl, G., & Trampisch, H.-J. (2004) · Atherosclerosis · doi:10.1016/s0021-9150(03)00204-1 · Cited by 828
Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816
Young, L. H., Wackers, F. J. T., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., et al. (2009) · JAMA · doi:10.1001/jama.2009.476 · Cited by 809 · cited 1×
“In the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study, 1123 asymptomatic patients with type 2 diabetes mellitus were randomly assigned to an adenosine-stress myocardial perfusion imaging or no screening.(66) Over the course of nearly 5 years of follow-up, there was no significant difference in the primar…”
MethodNinomiya, J. K., L’Italien, G., Criqui, M. H., Whyte, J. L., Gamst, A., & Chen, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000108926.04022.0c · Cited by 793
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804593 · Cited by 785
Pyörälä, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.131 · Cited by 768
Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W. A., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.791061 · Cited by 754
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
Hlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735
Geiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014) · JAMA · doi:10.1001/jama.2014.11494 · Cited by 672
Pericytes and the Pathogenesis of Diabetic Retinopathy
Hammes, H.-P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., & Deutsch, U. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3107 · Cited by 665
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651
Conte, M. S., Bandyk, D. F., Clowes, A. W., Moneta, G. L., Seely, L., Lorenz, T. J., Namini, H., Hamdan, A. D., Roddy, S. P., Belkin, M., et al. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.12.058 · Cited by 645
BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617
Sever, P. S., Dahl??f, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2004) · Drugs · doi:10.2165/00003495-200464002-00005 · Cited by 524
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
Park, S.-J., Ahn, J.-M., Kim, Y.-H., Park, D.-W., Yun, S.-C., Lee, J.-Y., Kang, S.-J., Lee, S.-W., Lee, C. W., Park, S.-W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415447 · Cited by 505
Nehler, M. R., Duval, S., Diao, L., Annex, B. H., Hiatt, W. R., Rogers, K., Zakharyan, A., & Hirsch, A. T. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.03.290 · Cited by 502
Effect of nateglinide on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001122 · Cited by 477
Pathophysiology of Diabetic Retinopathy
Tarr, J. M., Kaul, K., Chopra, M., Kohner, E. M., & Chibber, R. (2013) · ISRN Ophthalmology · doi:10.1155/2013/343560 · Cited by 455
James, S., Angiolillo, D. J., Cornel, J. H., Erlinge, D., Husted, S., Kontny, F., Maya, J., Nicolau, J. C., Spinar, J., Storey, R. F., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq325 · Cited by 446
Schramm, T. K., Gislason, G. H., Vaag, A., Rasmussen, J. N., Folke, F., Hansen, M. L., Fosbøl, E. L., Køber, L., Norgaard, M. L., Madsen, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr077 · Cited by 418
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Besseling, J., Kastelein, J. J. P., Defesche, J. C., Hutten, B. A., & Hovingh, G. K. (2015) · JAMA · doi:10.1001/jama.2015.1206 · Cited by 387
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & Idris, I. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377
Muhlestein, J. B., Lappé, D. L., Lima, J. A. C., Rosen, B. D., May, H. T., Knight, S., Bluemke, D. A., Towner, S. R., Le, V., Bair, T. L., et al. (2014) · JAMA · doi:10.1001/jama.2014.15825 · Cited by 373
Roussel, R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.409 · Cited by 361
CARDIORESPIRATORY DISEASE AND DIABETES AMONG MIDDLE-AGED MALE CIVIL SERVANTS
Reid, D. D., Hamilton, P. J. S., Keen, H., Brett, G. Z., Jarrett, R. J., & Rose, G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92783-4 · Cited by 343
Dyck, P. J., Davies, J. L., Wilson, D. M., Service, F. J., Melton, L. J., & O'Brien, P. C. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1479 · Cited by 328
Rajamani, K., Colman, P. G., Li, L. P., Best, J. D., Voysey, M., D'Emden, M. C., Laakso, M., Baker, J. R., & Keech, A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60698-x · Cited by 328
Smoking Cessation and the Risk of Stroke in Middle-aged Men
Wannamethee, S. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530020073035 · Cited by 325
Keech, A., Colquhoun, D., Best, J., Kirby, A., Simes, R. J., Hunt, D., Hague, W., Beller, E., Arulchelvam, M., Baker, J., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2713 · Cited by 313
Chung, S.-C., Gedeborg, R., Nicholas, O., James, S., Jeppsson, A., Wolfe, C., Heuschmann, P., Wallentin, L., Deanfield, J., Timmis, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62070-x · Cited by 297
Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis
Jayawardena, R., Ranasinghe, P., Byrne, N. M., Soares, M. J., Katulanda, P., & Hills, A. P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-380 · Cited by 296
Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease
Banning, A. P., Westaby, S., Morice, M.-C., Kappetein, A. P., Mohr, F. W., Berti, S., Glauber, M., Kellett, M. A., Kramer, R. S., Leadley, K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.057 · Cited by 290 · cited 1×
“In a subgroup of the Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) trial, diabetic patients with the highest SYNTAX risk score had a significantly improved survival when treated with coronary artery bypass grafting compared with PCI, whereas this finding was not noted in nondiabetic patients.(71) The ben…”
ResultEverolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease
Bangalore, S., Guo, Y., Samadashvili, Z., Blecker, S., Xu, J., & Hannan, E. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412168 · Cited by 288
Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study
Boden-Albala, B., Sacco, R. L., Lee, H.-S., Grahame-Clarke, C., Rundek, T., Elkind, M. V., Wright, C., Giardina, E.-G. V., DiTullio, M. R., Homma, S., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.496588 · Cited by 266
for the MAPS Investigators, Wu, A. Y. T., Kong, N. C. T., de Leon, F. A., Pan, C. Y., Tai, T. Y., Yeung, V. T. F., Yoo, S. J., Rouillon, A., & Weir, M. R. (2005) · Diabetologia · doi:10.1007/s00125-004-1599-9 · Cited by 249
Manson, J. E., Ajani, U. A., Liu, S., Nathan, D. M., & Hennekens, C. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00568-4 · Cited by 245
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes
Pignone, M., Alberts, M. J., Colwell, J. A., Cushman, M., Inzucchi, S. E., Mukherjee, D., Rosenson, R. S., Williams, C. D., Wilson, P. W., & Kirkman, M. S. (2010) · Diabetes Care · doi:10.2337/dc10-0555 · Cited by 242
Retinal Vascular Changes in Pre-Diabetes and Prehypertension
Nguyen, T. T., Wang, J. J., & Wong, T. Y. (2007) · Diabetes Care · doi:10.2337/dc07-0732 · Cited by 237
Zuanetti, G., Latini, R., Maggioni, A. P., Franzosi, M., Santoro, L., & Tognoni, G. (1997) · Circulation · doi:10.1161/01.cir.96.12.4239 · Cited by 235
Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning
Dolan, N. C., Liu, K., Criqui, M. H., Greenland, P., Guralnik, J. M., Chan, C., Schneider, J. R., Mandapat, A. L., Martin, G., & McDermott, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.113 · Cited by 230
Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan
Tseng, C.-H. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1605 · Cited by 226
Hooi, J. D., Kester, A. D. M., Stoffers, H. E. J. H., Overdijk, M. M., van Ree, J. W., & Knottnerus, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.7.666 · Cited by 221
The risk of venous thromboembolism is markedly elevated in patients with diabetes
Petrauskiene, V., Falk, M., Waernbaum, I., Norberg, M., & Eriksson, J. W. (2005) · Diabetologia · doi:10.1007/s00125-005-1715-5 · Cited by 218
Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes
Janghorbani, M., Hu, F. B., Willett, W. C., Li, T. Y., Manson, J. E., Logroscino, G., & Rexrode, K. M. (2007) · Diabetes Care · doi:10.2337/dc06-2363 · Cited by 212
Armstrong, E. J., Wu, J., Singh, G. D., Dawson, D. L., Pevec, W. C., Amsterdam, E. A., & Laird, J. R. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.08.064 · Cited by 202
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Chaturvedi, N., Bandinelli, S., Mangili, R., Penno, G., Rottiers, R. E., & Fuller, J. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00789.x · Cited by 191
Wattanakit, K., Folsom, A. R., Selvin, E., Weatherley, B. D., Pankow, J. S., Brancati, F. L., & Hirsch, A. T. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.024 · Cited by 184
Blood pressure control for diabetic retinopathy
Diana, V., Wang, X., Vedula, S. S., Marrone, M. T., Sleilati, G. G., Hawkins, B. S., & Frank, R. N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006127.pub2 · Cited by 179
Natural history of claudication: Long-term serial follow-up study of 1244 claudicants
Aquino, R., Johnnides, C., Makaroun, M., Whittle, J. C., Muluk, V. S., Kelley, M. E., & Muluk, S. C. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.119749 · Cited by 163
Taylor, S. M., Kalbaugh, C. A., Blackhurst, D. W., Cass, A. L., Trent, E. A., Langan, E. M., & Youkey, J. R. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.06.015 · Cited by 161
Laakso, M., Rönnemaa, T., Pyörälà, K., Kallio, V., Puukka, P. J., & Penttilä, I. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.449 · Cited by 153
Long-Term Outcome of PCI Versus CABG in Insulin and Non–Insulin-Treated Diabetic Patients
Dangas, G., Farkouh, M. E., Sleeper, L. A., YANG, M. H., Schoos, M. M., Macaya, C., Abizaid, A., Buller, C. E. H., Devlin, G. P., Rodríguez, A. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1182 · Cited by 149
Antihypertensive agents for preventing diabetic kidney disease
Lv, J., Perkovic, V., Foote, C., Craig, M. E., Craig, J. C., & Strippoli, G. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004136.pub3 · Cited by 148
Sivaprasad, S., Gupta, B., Gulliford, M. C., Dodhia, H., Mohamed, M. D., Nagi, D. K., & Evans, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032182 · Cited by 142
Daly, C., Fox, K. M., Remme, W. J., Bertrand, M. E., Ferrari, R., & Simoons, M. L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi225 · Cited by 142
Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
Knowles, J. W., Xie, W., Zhang, Z., Chennemsetty, I., Assimes, T. L., Paananen, J., Hansson, O., Pankow, J., Goodarzi, M. O., Carcamo-Orive, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74692 · Cited by 141
Redefining Blood-Pressure Targets — SPRINT Starts the Marathon
Perkovic, V., & Rodgers, A. (2015) · New England Journal of Medicine · doi:10.1056/nejme1513301 · Cited by 136
Abubakari, A. R., Lauder, W., Jones, M. C., Kirk, A. F., Agyemang, C. O., & Bhopal, R. S. (2009) · Public Health · doi:10.1016/j.puhe.2009.07.009 · Cited by 135
Smoking and Mortality Among Women With Type 2 Diabetes
Al‐Delaimy, W. K., Willett, W. C., Manson, J. E., Speizer, F. E., & Hu, F. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2043 · Cited by 133
Diabetes, Fasting Glucose Levels, and Risk of Ischemic Stroke and Vascular Events
Boden-Albala, B., Cammack, S., Chong, J., Wang, C., Wright, C., Rundek, T., Elkind, M. S. V., Paik, M. C., & Sacco, R. L. (2008) · Diabetes Care · doi:10.2337/dc07-0797 · Cited by 132
Tang, W. H., Stitham, J., Gleim, S., Febbo, C. D., Porreca, E., Fava, C., Tacconelli, S., Capone, M. L., Evangelista, V., Levantesi, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59291 · Cited by 129
Callahan, A., Amarenco, P., Goldstein, L. B., Sillesen, H., Messig, M., Samsa, G. P., Altafullah, I., Ledbetter, L. Y., MacLeod, M. J., Scott, R., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.146 · Cited by 124
Mirshahi, A., Roohipoor, R., Lashay, A., Mohammadi, S.-F., Abdoallahi, A., & Faghihi, H. (2008) · European Journal of Ophthalmology · doi:10.1177/112067210801800215 · Cited by 123
Heit, J. A., Leibson, C. L., Ashrani, A. A., Petterson, T. M., Bailey, K. R., & Melton, L. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.189290 · Cited by 121
Zuo, H., Shi, Z., & Hussain, A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.002 · Cited by 119
Bressler, S. B., Qin, H., Melia, M., Bressler, N. M., Beck, R. W., Chan, C. K., Grover, S., & Miller, D. G. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4154 · Cited by 119
(2004) · PubMed · Cited by 118
Schmidt, M., Schmidt, S. A. J., Lemeshow, S. A., Lash, T. L., Ulrichsen, S. P., Bøtker, H. E., & Sørensen, H. T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002698 · Cited by 114
(2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2015 · Cited by 113
Trends in Diabetes Incidence: The Framingham Heart Study
Abraham, T. M., Pencina, K. M., Pencina, M. J., & Fox, C. S. (2015) · Diabetes Care · doi:10.2337/dc14-1432 · Cited by 110
Conen, D., Everett, B. M., Kurth, T., Creager, M. A., Buring, J. E., Ridker, P. M., & Pradhan, A. D. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-11-201106070-00003 · Cited by 109
Self-citationUniformity of captopril benefit in the SAVE study: subgroup analysis
Moyé, L. A., Pfeffer, M. A., Wun, C. C., Davis, B. R., Geltman, E. M., Hayes, D. L., Farnham, D. J., Randall, O. S., Dinh, H., Arnold, J. M. O., et al. (1994) · European Heart Journal · doi:10.1093/eurheartj/15.suppl_b.2 · Cited by 107
Exertional Leg Pain in Patients With and Without Peripheral Arterial Disease
Wang, J. C., Criqui, M. H., Denenberg, J. O., McDermott, M. M., Golomb, B. A., & Fronek, A. (2005) · Circulation · doi:10.1161/circulationaha.105.548099 · Cited by 107
Tanaka, R., Ueno, Y., Miyamoto, N., Yamashiro, K., Tanaka, Y., Shimura, H., Hattori, N., & Urabe, T. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.06.010 · Cited by 103
Song, Y.-M., & Cho, H.-J. (2008) · Stroke · doi:10.1161/strokeaha.107.512632 · Cited by 101
Outcome After Leg Bypass Surgery for Critical Limb Ischemia Is Poor in Patients With Diabetes
Malmstedt, J., Leander, K., Wahlberg, E., Karlström, L., Alfredsson, L. S., & Swedenborg, J. (2008) · Diabetes Care · doi:10.2337/dc07-2424 · Cited by 100
Dyck, P. J., Davies, J. L., Clark, V. M., Litchy, W. J., Dyck, P. J. B., Klein, C. J., Rizza, R. A., Pach, J. M., Klein, R., Larson, T. S., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0525 · Cited by 99
Giannini, C., & Dyck, P. J. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360312 · Cited by 98
(1994) · Diabetes Care · doi:10.2337/diacare.17.11.1357 · Cited by 96
Susceptibility to type 2 diabetes mellitus—from genes to prevention
Hivert, M., Vassy, J. L., & Meigs, J. B. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.11 · Cited by 87
Cui, R., Iso, H., Yamagishi, K., Saito, I., Kokubo, Y., Inoue, M., & Tsugane, S. (2011) · Stroke · doi:10.1161/strokeaha.111.614313 · Cited by 87
Bai, J., Ding, X., Du, X., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.11.003 · Cited by 85
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus
Mishra, N. K., Ahmed, N., Dávalos, A., Iversen, H. K., Melo, T. P. E., Soinne, L., Wahlgren, N. G., Lees, K. R., & collaborators, F. T. S. A. V. (2011) · Neurology · doi:10.1212/wnl.0b013e318238ee42 · Cited by 83
Changes in Blood Coagulation, Platelet Function, and Plasminogen-Plasmin System in Diabetes
Kwaan, H. C. (1992) · Diabetes · doi:10.2337/diab.41.2.s32 · Cited by 80
Cavender, M. A., Scirica, B. M., Bonaca, M. P., Angiolillo, D. J., Dalby, A. J., Dellborg, M., Morais, J., Murphy, S. A., Ophuis, T. O., Tendera, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013774 · Cited by 80
The impact of cardiovascular disease on people with diabetes: the potential for prevention
Eastman, R. C., & Keen, H. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90026-x · Cited by 76
Diabetes Mellitus and Risk of Venous Thromboembolism
Stein, P. D., Goldman, J., Matta, F., & Yaekoub, A. Y. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31818bbb8b · Cited by 76
Nagrebetsky, A., Brettell, R., Roberts, N. W., & Farmer, A. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004107 · Cited by 76
Arnold, M., Mattle, S., Galimanis, A., Kappeler, L., Fischer, U., Jung, S., Marchis, G. M. D., Gralla, J., Mono, M., Brekenfeld, C., et al. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00879.x · Cited by 72
From Pathobiology to the Targeting of Pericytes for the Treatment of Diabetic Retinopathy
Arboleda‐Velásquez, J. F., Valdez, C. N., Marko, C. K., & D'Amore, P. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0573-2 · Cited by 68
Ford, E. S., Roger, V. L., Dunlay, S. M., Go, A. S., & Rosamond, W. D. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001097 · Cited by 62
Is diabetes a hypercoagulable state? A critical appraisal
Pomero, F., Minno, M. N. D. D., Fenoglio, L. M., Gianni, M., Ageno, W., & Dentali, F. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0746-8 · Cited by 59
Type 2 diabetes is associated with a worse functional outcome of ischemic stroke
Τζιόμαλος, Κ. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.939 · Cited by 55
Ahmed, B., Davis, H., & Laskey, W. K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001090 · Cited by 54
Long Term Postischemic Stroke Mortality in Diabetes
Kamalesh, M., Shen, J., & Eckert, G. J. (2008) · Stroke · doi:10.1161/strokeaha.108.517441 · Cited by 49
Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes
Zhu, S., McClure, L. A., Lau, H. W., Romero, J. R., White, C. L., Babikian, V. L., Nguyen, T. N., Benavente, O., Kase, C. S., & Pikula, A. (2015) · Neurology · doi:10.1212/wnl.0000000000001933 · Cited by 45
Pathophysiology and treatment of painful diabetic neuropathy
Tavakoli, M., Mojaddidi, M. A., Fadavi, H., & Malik, R. A. (2008) · Current Pain and Headache Reports · doi:10.1007/s11916-008-0034-1 · Cited by 45
Time-Dependent Impact of Diabetes on Mortality in Patients With Stroke
Icks, A., Claessen, H., Morbach, S., Glaeske, G., & Hoffmann, F. (2012) · Diabetes Care · doi:10.2337/dc11-2159 · Cited by 43
Torp-Pedersen, C., Køber, L., & Carlsen, J. E. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90559-1 · Cited by 40
Chen, Y.-W., Wang, Y.-Y., Zhao, D., Yu, C., Zhong, X., Cao, X., Shi, J. C., Yang, G.-R., Yuan, M., & Yang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122022 · Cited by 40
Gupta, A. K., Dahlöf, B., Sever, P., Poulter, N. R., & for the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) investigators (2010) · Diabetes Care · doi:10.2337/dc09-2208 · Cited by 40
Mi, D., Jia, Q., Zheng, H., Hoff, K., Zhao, X., Wang, C., Liu, G., Wang, Y., Liu, L., Wang, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051406 · Cited by 38
Yeap, B. B., McCaul, K. A., Flicker, L. A., Hankey, G. J., Almeida, O. P., Golledge, J., & Norman, P. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3339 · Cited by 37
Risk Factors for Lower-Extremity Vein Graft Failure
Monahan, T. S., & Owens, C. D. (2009) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2009.10.003 · Cited by 34
Thukkani, A. K., Agrawal, K., Prince, L., Smoot, K. J., Dufour, A. B., Cho, K., GAGNON, D. R., Sokolovskaya, G., Ly, S., Temiyasathit, S., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1339 · Cited by 33
Primary prevention of diabetic retinopathy with fibrates: A retrospective, matched cohort study
Morgan, C. L., Owens, D. R., Aubonnet, P., Carr, E. S. M., Jenkins-Jones, S., Poole, C. D., & Currie, C. J. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-004025 · Cited by 31
The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease
Faries, P. L., LoGerfo, F. W., Hook, S. C., Pulling, M. C., Akbari, C. M., Campbell, D. R., & Pomposelli, F. B. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(01)00551-7 · Cited by 30
Bassand, J. (1994) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060374 · Cited by 29
Lange, S., Diehm, C., Darius, H., Haberl, R. L., Allenberg, J. R., Pittrow, D., Schuster, A. K.-G., von Stritzky, B., Tepohl, G., & Trampisch, H. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3357 · Cited by 27
Forbang, N. I., McDermott, M. M., Liao, Y., Ix, J. H., Allison, M., Liu, K., Tian, L., Evans, N., & Criqui, M. H. (2014) · Vascular Medicine · doi:10.1177/1358863x14554033 · Cited by 27
Bennet, A. M., Brismar, K., Hallqvist, J., Reuterwall, C., & Fairé, U. D. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470641 · Cited by 24
Vu, T. T., Stamler, J., Liu, K., McDermott, M. M., Lloyd‐Jones, D. M., Pirzada, A., Garside, D. B., & Daviglus, M. L. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.001545 · Cited by 22
Yang, M., Chen, H., Johnson, M. L., Essien, E. J., Peters, R. J., Wu, I.-H., & Abughosh, S. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1023457 · Cited by 2
Cited by
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Diabetes, infection risk and COVID-19
Erener, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101044 · Cited by 351
Gupta, S., Dominguez, M., & Golestaneh, L. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.004 · Cited by 337
Thipsawat, S. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211058856 · Cited by 307
Metadata
- Authors
- Beckman, J. A., & Creager, M. A.
- Venue
- Circulation Research
- Published
- 2016-05-27
- Volume
- 118
- Issue
- 11
- Pages
- 1771-1785
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2399602153
- Cited by
- 412
- References
- 186
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.